A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD2.13
- USD2.17
- USD2.00
- USD3.36
- 62.40%
- --
- 193.74k
- 412.96k
- 130M
- 0.86
- -23.70%
Stock News
7 hours ago
VNQ: Sell Your REIT ETFs
SeekingAlpha
7 hours ago
Magnolia Oil & Gas: Capable Of Generating Significant FCF At High-$50s Oil (Rating Upgrade)
SeekingAlpha
8 hours ago
Vox Royalty: Acquisitions And Commodity Tailwinds Fuel Growth
SeekingAlpha
9 hours ago
S&P 500 Snapshot: Volatile See-Saw Week
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
